Alnylam Pharmaceuticals | ALNY - Los Ingresos Por Intereses





Los Ingresos Por Intereses Cambio Fecha
Acadia Pharmaceuticals USD 8.06M 277K 2026-03
Agios Pharmaceuticals USD 10.8M 1.62M 2026-03
Alnylam Pharmaceuticals USD 26.6M 32K 2026-03
Arrowhead Research USD 16.93M 66K 2026-06
BioCryst Pharmaceuticals USD -0.13 3.59M 2024-12
BioMarin Pharmaceutical USD 22.56M 3.35M 2026-03
Incyte USD 38.12M 4.43M 2026-06
Ionis Pharmaceuticals USD -0.66 0.29 2024-12
Moderna USD 72M 2M 2026-03
Regeneron Pharmaceuticals USD 183.3M 200K 2026-06
Sanofi EUR 60M 54M 2026-03
Sarepta Therapeutics USD 7M 1.74M 2026-03
Takeda JPY 24.61B 213.76B 2026-06
Tectonic Therapeutic USD 1.74M 217K 2024-12
Ultragenyx Pharmaceutical USD 6M 512K 2026-03
Vertex Pharmaceuticals USD 120.6M 5.8M 2026-06
Xencor USD 5.46M 741K 2026-03